Clinical Trial: Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Double-masked, Multicenter, Controlled Study of Photodynamic Therapy in Patients With Central Serous Chorioretinopathy
Brief Summary: The purpose of this study is to determine the safety and efficacy of PDT at 30% verteporfin dose in the treatment of CSC.
Detailed Summary:
Sponsor: Peking University People's Hospital
Current Primary Outcome: Change from baseline in BCVA [ Time Frame: 1 week,2 weeks,3 weeks,1 month,3months, 6 months, 1 year ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Leakage at RPE level in FA [ Time Frame: 1 week ]
- Change from baseline in central retinal thickness [ Time Frame: 1 week,2 weeks,3 weeks,1 month,3months, 6 months, 1 year ]
- The incidence rate of adverse event [ Time Frame: 1 week,2 weeks,3 weeks,1 month,3months, 6 months, 1 year ]
Original Secondary Outcome: Same as current
Information By: Peking University People's Hospital
Dates:
Date Received: April 8, 2012
Date Started: December 2010
Date Completion:
Last Updated: August 15, 2016
Last Verified: August 2016
